Breakout Stocks for Tomorrow: Delhivery, Samvardhana Motherson International and Aurobindo Pharma have broken above key resistance levels with strong volumes and improving relative strength. Their technical setups, recent financial performance and business growth make these three stocks worth tracking for swing trading this week.
Breakout Stocks for Tomorrow: Every trader is on the lookout for swing trading opportunities that can deliver quick gains. However, chasing stocks that have already rallied 20% or 30% is a very risky approach. A much better and safer strategy is to focus on companies that are breaking out after a long period of consolidation meaning they have spent months or even years moving sideways in a tight range.
When you combine this technical outperformance with solid business execution, favorable corporate disclosures, and a positive growth outlook, the chances of a successful trade increase significantly.
That is why we have shortlisted 3 breakout stocks for today: Delhivery, Samvardhana Motherson International, and Aurobindo Pharma. All 3 of these companies are currently trading near crucial breakout zones. Supported by an improving Relative Strength against the BSE 500, these charts show a classic transition from consolidation to a potential uptrend.
Breakout Stocks for Swing Trade
Here are 3 breakout stocks for tomorrow, for your study
1. Delhivery (CMP:507)
Note: The chart is as of 5th July 2026 and is shared only for educational purposes. It should not be considered an investment recommendation.
1. Technical View
Delhivery has delivered a strong technical breakout after consolidating below the key ₹480–₹486 resistance zone for nearly 2 years, from February 2024 to June 2026. In the first week of July 2026, the stock broke above this long-standing resistance with a strong bullish candle and a sharp rise in trading volumes, confirming strong buying interest.
The breakout completes a classic Cup and Handle pattern, one of the most reliable bullish continuation formations. Delhivery’s Relative Strength (RS) against the BSE 500 has also been steadily improving and is now approaching a Zero Line crossover, suggesting the stock could continue to outperform the broader market.
2. Business Overview
Delhivery is one of India’s leading integrated logistics companies, offering services such as express parcel delivery, heavy goods transportation, PTL and TL freight, warehousing, supply chain solutions, and cross-border logistics. It also provides e-commerce returns management, payment collection, product installation, and fraud detection services, making it a comprehensive logistics partner for businesses.
3. Financial Performance
Delhivery has reported strong financial performance over the last 2 quarters, with revenue growing 18% and 30%, respectively. Profit surged 80% in the latest quarter and 18% year-on-year. Domestic Institutional Investors (DIIs) have increased their stake from 34.98% in December 2025 to 36.27%, reflecting growing institutional confidence. Supported by improving business performance, market expectations remain positive for the company’s upcoming quarterly results.
2. Samvardhana Motherson International Ltd ( CMP: 146)
Note: The chart is as of 5th July 2026 and is shared only for educational purposes. It should not be considered an investment recommendation.
1. Technical View
Samvardhana Motherson International has delivered a strong technical breakout by crossing its previous all-time high of ₹144, a level that had acted as a major resistance since September 2024. The breakout follows the formation of a Rounding Bottom pattern, a widely followed chart formation that often signals the beginning of a sustained uptrend. The move was supported by a strong bullish candle and rising trading volumes, indicating healthy buying interest. The stock’s Relative Strength (RS) against the BSE 500 has also crossed above the Zero Line, suggesting it could continue to outperform the broader market.
2. Business Overview
Samvardhana Motherson International is one of India’s largest auto component manufacturers, supplying products to leading automobile companies worldwide. Its portfolio includes wiring harnesses, vision systems, polymer modules, metal components, HVAC systems, aerospace parts, and technology services. With a diversified business model and a strong global manufacturing footprint, the company serves multiple industries beyond automobiles.
3. Financial Performance
Samvardhana Motherson has delivered consistent long-term growth, with 17% sales CAGR over the last 3 and 5 years. Profit has grown even faster, recording a 39% CAGR over 3 years and 31% CAGR over 5 years. The company maintains healthy return ratios, with a ROCE of 13.1% and ROE of 10.9%. FIIs have also increased their stake from 11.75% in December 2025 to 12.45% in March 2026, reflecting growing institutional confidence.
3. Aurobindo Pharma (CMP: 146)
Note: The chart is as of 5th July 2026 and is shared only for educational purposes. It should not be considered an investment recommendation.
1. Technical View
Aurobindo Pharma has delivered a strong technical breakout by crossing the key ₹1,575 resistance level, which had remained intact since September 2024. The breakout follows the formation of a Rounding Bottom pattern, a widely followed chart formation that often signals the beginning of a sustained uptrend.
The move was supported by a large bullish candle and a sharp rise in trading volumes, confirming strong buying interest. The stock’s Relative Strength (RS) against the BSE 500 also remains positive and continues to trend higher, suggesting it could outperform the broader market.
READ THIS ALSO: 3 Breakout Stocks for Swing Trading
2. Business Overview
Aurobindo Pharma is one of India’s leading pharmaceutical companies and the country’s second-largest listed pharma company by revenue. It is also the largest generic drug manufacturer in the US and ranks among the top generic players across several European markets. The company manufactures generic medicines, APIs, injectables, specialty drugs, and OTC products. With exports to over 150 countries and 29 manufacturing facilities across India, the US, Portugal, and Brazil, it has built a strong global presence.
3. Financial Performance
Aurobindo Pharma has delivered steady financial growth, recording a sales CAGR of 11% and a profit CAGR of 23% over the last three years. The stock has also generated a 36% return over the past year, while maintaining a ROE of 10%. FIIs have increased their stake from 13.95% in December 2025 to 15.24% in March 2026, reflecting growing institutional confidence in the company’s long-term growth prospects.
READ THIS ALSO: Rounding Bottom: Meaning, Formation, and How to Trade
Conclusion
Delhivery, Samvardhana Motherson International, and Aurobindo Pharma are showing a combination of strong business performance and positive market sentiment. All 3 breakout stocks for next week have broken above important resistance levels, supported by improving volumes and rising Relative Strength against the BSE 500, indicating better performance than the broader market.
Delhivery is benefiting from strong growth in logistics, Motherson from its diversified global auto-component business, and Aurobindo from its strong presence in generics and APIs. While no stock is risk-free, the current setup suggests these companies could remain key stocks to watch in the coming quarters.